In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.
The global energy transition is unlocking key market opportunities and supply chain challenges through 2036. With rising demand for rare earth magnets, electrolyzer catalyst materials, and battery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results